These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 19111616

  • 1. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW.
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [Abstract] [Full Text] [Related]

  • 2. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M, Berger P, Nave KA, Suter U.
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [Abstract] [Full Text] [Related]

  • 3. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A.
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA.
    Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
    [Abstract] [Full Text] [Related]

  • 5. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J, Awatramani R, Menichella D, Jiang H, Xu W, Shy M.
    Ann N Y Acad Sci; 1999 Sep 14; 883():91-108. PubMed ID: 10586235
    [Abstract] [Full Text] [Related]

  • 6. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW.
    J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042
    [Abstract] [Full Text] [Related]

  • 7. Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model.
    ten Asbroek AL, Verhamme C, van Groenigen M, Wolterman R, de Kok-Nazaruk MM, Baas F.
    J Neurosci Res; 2005 Mar 15; 79(6):825-35. PubMed ID: 15672449
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies.
    Hai M, Muja N, DeVries GH, Quarles RH, Patel PI.
    J Neurosci Res; 2002 Aug 15; 69(4):497-508. PubMed ID: 12210843
    [Abstract] [Full Text] [Related]

  • 9. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
    Kuhn G, Lie A, Wilms S, Müller HW.
    Glia; 1993 Aug 15; 8(4):256-64. PubMed ID: 7691737
    [Abstract] [Full Text] [Related]

  • 10. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
    Kobsar I, Hasenpusch-Theil K, Wessig C, Müller HW, Martini R.
    J Neurosci Res; 2005 Sep 15; 81(6):857-64. PubMed ID: 16041800
    [Abstract] [Full Text] [Related]

  • 11. Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice.
    Guénard V, Schweitzer B, Flechsig E, Hemmi S, Martini R, Suter U, Schachner M.
    Glia; 1999 Jan 15; 25(2):165-78. PubMed ID: 9890631
    [Abstract] [Full Text] [Related]

  • 12. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
    Fortun J, Go JC, Li J, Amici SA, Dunn WA, Notterpek L.
    Neurobiol Dis; 2006 Apr 15; 22(1):153-64. PubMed ID: 16326107
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
    Fortun J, Li J, Go J, Fenstermaker A, Fletcher BS, Notterpek L.
    J Neurochem; 2005 Mar 15; 92(6):1531-41. PubMed ID: 15748170
    [Abstract] [Full Text] [Related]

  • 16. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R, Suter U.
    Microsc Res Tech; 1998 Jun 01; 41(5):359-71. PubMed ID: 9672419
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S, Young P, Suter U.
    Brain; 2001 Nov 01; 124(Pt 11):2177-87. PubMed ID: 11673320
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 upregulates the expression of PMP22 in cultured rat Schwann cells via a JAK2-dependent pathway.
    Ito T, Ikeda K, Tomita K, Yokoyama S.
    Neurosci Lett; 2010 Mar 19; 472(2):104-8. PubMed ID: 20122990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.